Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Net Income: 2020-2025

Historic Net Income for Silence Therapeutics (SLN) over the last 6 years, with Sep 2025 value amounting to -$21.0 million.

  • Silence Therapeutics' Net Income rose 41.04% to -$21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.5 million, marking a year-over-year increase of 24.27%. This contributed to the annual value of -$45.3 million for FY2024, which is 16.45% up from last year.
  • According to the latest figures from Q3 2025, Silence Therapeutics' Net Income is -$21.0 million, which was up 23.38% from -$27.4 million recorded in Q2 2025.
  • In the past 5 years, Silence Therapeutics' Net Income registered a high of $12.3 million during Q4 2024, and its lowest value of -$35.5 million during Q3 2024.
  • Over the past 3 years, Silence Therapeutics' median Net Income value was -$18.6 million (recorded in 2023), while the average stood at -$16.8 million.
  • Per our database at Business Quant, Silence Therapeutics' Net Income soared by 166.23% in 2024 and then plummeted by 1,134.00% in 2025.
  • MRQ analysis of 5 years shows Silence Therapeutics' Net Income stood at -$15.1 million in 2021, then decreased by 16.64% to -$17.7 million in 2022, then decreased by 5.23% to -$18.6 million in 2023, then surged by 166.23% to $12.3 million in 2024, then tumbled by 270.36% to -$21.0 million in 2025.
  • Its last three reported values are -$21.0 million in Q3 2025, -$27.4 million for Q2 2025, and -$28.5 million during Q1 2025.